GB9920578D0 - Composition for maintenance of bone or dental health or treatment of bone or dental disorders - Google Patents

Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Info

Publication number
GB9920578D0
GB9920578D0 GBGB9920578.3A GB9920578A GB9920578D0 GB 9920578 D0 GB9920578 D0 GB 9920578D0 GB 9920578 A GB9920578 A GB 9920578A GB 9920578 D0 GB9920578 D0 GB 9920578D0
Authority
GB
United Kingdom
Prior art keywords
bone
dental
maintenance
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9920578.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Priority to GBGB9920578.3A priority Critical patent/GB9920578D0/en
Publication of GB9920578D0 publication Critical patent/GB9920578D0/en
Priority to AU68385/00A priority patent/AU6838500A/en
Priority to PCT/EP2000/007919 priority patent/WO2001015715A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
GBGB9920578.3A 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders Ceased GB9920578D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9920578.3A GB9920578D0 (en) 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders
AU68385/00A AU6838500A (en) 1999-08-31 2000-08-14 Composition for maintenance of bone or dental health or treatment of bone or dental disorders
PCT/EP2000/007919 WO2001015715A2 (en) 1999-08-31 2000-08-14 Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920578.3A GB9920578D0 (en) 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Publications (1)

Publication Number Publication Date
GB9920578D0 true GB9920578D0 (en) 1999-11-03

Family

ID=10860095

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9920578.3A Ceased GB9920578D0 (en) 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Country Status (3)

Country Link
AU (1) AU6838500A (en)
GB (1) GB9920578D0 (en)
WO (1) WO2001015715A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100866008B1 (en) 1999-10-19 2008-10-29 메이지 데어리즈 코포레이션 Preventives/remedies for metabolic bone diseases
JP4268785B2 (en) * 2002-04-11 2009-05-27 株式会社ロッテ Calcium absorption promoter and calcium phosphate crystal growth promoter
US6872565B2 (en) 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
US7517681B2 (en) 2003-01-29 2009-04-14 Biogaia Ab Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
JP2004315477A (en) * 2003-04-18 2004-11-11 Tokyoto Koreisha Kenkyu Fukushi Shinko Zaidan Bone resorption inhibitor
JP2008503563A (en) 2004-06-23 2008-02-07 ロレアル Methods and compositions useful for the prevention and / or treatment of sensitive and / or dry skin
FR2872047B1 (en) * 2004-06-23 2007-06-15 Oreal COMPOSITION FOR SENSITIVE SKINS COMBINING MINERAL AND PROBIOTIC CATION (S)
US7956031B2 (en) 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
SE529199C2 (en) 2005-07-05 2007-05-29 Probi Ab Increased absorption
US8021659B2 (en) * 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
FR2920304B1 (en) 2007-09-04 2010-06-25 Oreal COSMETIC USE OF LYSAT BIFIDOBACTERIUM SPECIES FOR THE TREATMENT OF DROUGHT.
FR2920305B1 (en) 2007-09-04 2010-07-30 Oreal USE OF A SPECIFIC BIFIDOBACTERIUM LYSATE FOR THE TREATMENT OF SENSITIVE SKINS.
WO2010036876A2 (en) 2008-09-25 2010-04-01 New York University Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
FR2942719B1 (en) 2009-03-04 2011-08-19 Oreal USE OF PROBIOTIC MICROORGANISMS TO LIMIT SKIN IRRITATION
ES2365145B1 (en) * 2009-09-17 2012-09-13 Danone, S.A. FERMENTED PASTERIZED DAIRY PRODUCT AND PREPARATION PROCEDURE OF THE SAME.
EP2477503B1 (en) * 2009-09-17 2013-07-31 Danone, S.A. Process for preparing a pasteurised and fermented dairy product supplemented with calcium and vitamin d
US8951512B2 (en) * 2010-05-04 2015-02-10 New York University Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
WO2012024638A2 (en) 2010-08-20 2012-02-23 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
PL2981274T3 (en) * 2013-04-03 2020-12-28 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
CN104152354A (en) * 2013-05-14 2014-11-19 仙农生物科技(上海)有限公司 Compound probiotics as well as production process and application thereof to leavening agent
KR102443570B1 (en) 2013-07-05 2022-09-14 인테그라 메디컬 인코포레이티드 Oral compositions
CN104186655B (en) * 2014-08-27 2016-06-29 内蒙古伊利实业集团股份有限公司 There is low-fat yogurt of blood fat reducing and anti-oxidation function and preparation method thereof
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
CN106858605A (en) * 2016-12-26 2017-06-20 吉林舒润生物科技有限公司 A kind of probiotics calcium functional food for preventing and treating bone information relevant disease
CN108245479B (en) * 2017-09-19 2020-11-20 魏珂 Facial mask containing bifidobacterium lactis fermented active extract
CN110964656B (en) * 2018-09-30 2021-05-28 内蒙古伊利实业集团股份有限公司 Bifidobacterium lactis BL-99 capable of preventing osteoporosis and application thereof
WO2020063553A1 (en) 2018-09-30 2020-04-02 内蒙古伊利实业集团股份有限公司 Bifidobacterium lactis bl-99 and application thereof
WO2021112041A1 (en) * 2019-12-02 2021-06-10 雪印メグミルク株式会社 Bone-strengthening agent
KR102198552B1 (en) * 2020-06-09 2021-01-05 주식회사 비피도 Composition improving, preventing or treating halitosis or dental caries comprising Lactobacillus fermentum OK derived from human oral cavity
KR102198553B1 (en) * 2020-06-09 2021-01-05 주식회사 비피도 Composition improving, preventing or treating halitosis or dental caries comprising Lactobacillus gasseri HHuMIN D derived from human oral cavity
CN114711355A (en) * 2022-04-21 2022-07-08 暨南大学 Composite organic acid high-calcium probiotic drink taking astragalus polysaccharide as raw material as well as preparation method and application thereof
CN116904378B (en) * 2023-09-14 2023-12-29 山东中科嘉亿生物工程有限公司 Lactobacillus johnsonii JYLO-010 for promoting bone growth, microbial inoculum and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273485A3 (en) * 1986-11-25 1988-07-27 Verenigde Coöperatieve Melkindustrie Coberco B.A. A process for preparing a raw material for human food; human food; a process for preparing a pharmaceutical composition
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same

Also Published As

Publication number Publication date
AU6838500A (en) 2001-03-26
WO2001015715A2 (en) 2001-03-08
WO2001015715A3 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
GB9920578D0 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
PL351134A1 (en) Compositions for treatment of disorders of the oesophagus
IL147440A0 (en) Composition for treatment of external secretion disorders
HUP9802319A3 (en) Pharmaceutical compositions for treatment of bone deficit conditions
EP0961613A4 (en) Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
IL139591A0 (en) Combination therapy for treatment of bipolar disorders
AU7434101A (en) Treatment of bone diseases
HUP0401427A3 (en) Oral compositions for the treatment of scalp disorders
EP1173470A4 (en) Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
IL146131A0 (en) Treatment of neurotic disorders
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU2002362115A8 (en) Composition and methods for treatment of neurological disorders
EP1420718A4 (en) Resorbable prosthesis for medical treatment
HUP0402267A3 (en) Method for treatment of bone disorders
HUP0101748A3 (en) Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disorders
EP1440163A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 46566
GB9904252D0 (en) Composition for the treatment of pain
EP1440169A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 57749
EP1439862A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 9805
TWI345980B (en) Pharmaceutical compositions for preventing or treating injuries of brain tissue
AU2003245011A8 (en) Method and compositions for treatment of bone disorders
EP1448152A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 2047
GB9918000D0 (en) Compositions for the treatment of pain
GB0324283D0 (en) Therapeutic agents for the treatment of bone disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)